Every SEC Form 3/4/5 on record for this filer (CIK 1272181) — 6 issuers, 19 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| IMNM | Immunome Inc. | Director | 2024-01-04 → 2026-06-12 | 5 | — |
| KURA | Kura Oncology, Inc. | Director | 2021-06-04 → 2026-06-04 | 8 | — |
| INSM | INSMED Inc | Director | 2020-04-02 → 2026-05-15 | 9 | — |
| RPTX | Repare Therapeutics Inc. | Director | 2020-06-18 → 2026-01-28 | 7 | $160,000 |
| IDRA | IDERA PHARMACEUTICALS, INC. | Director · lapsed | 2018-12-20 → 2022-06-27 | 14 | $16,650 |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Director · lapsed | 2019-05-16 → 2021-04-19 | 5 | — |
No open-market buy or sale on record — only grants, exercises, withholding or gifts. Switch to “All forms” to see them.
3 of 6 issuers are covered and open a security page; the rest are on file here only.